Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 2036 | 2.070 |
Why?
|
| Brain | 24 | 2023 | 1569 | 1.940 |
Why?
|
| Transcriptome | 9 | 2023 | 82 | 1.670 |
Why?
|
| Proteomics | 6 | 2022 | 84 | 1.120 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 133 | 1.080 |
Why?
|
| Algorithms | 4 | 2023 | 345 | 1.060 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 990 | 1.020 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 27 | 0.930 |
Why?
|
| Proteome | 3 | 2022 | 35 | 0.930 |
Why?
|
| RNA, Messenger | 3 | 2022 | 306 | 0.900 |
Why?
|
| Cluster Analysis | 2 | 2023 | 43 | 0.700 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 266 | 0.660 |
Why?
|
| Nerve Net | 2 | 2019 | 38 | 0.660 |
Why?
|
| Dementia | 2 | 2022 | 524 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 366 | 0.550 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 268 | 0.510 |
Why?
|
| Models, Neurological | 1 | 2016 | 24 | 0.510 |
Why?
|
| Humans | 41 | 2023 | 25967 | 0.490 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 4641 | 0.470 |
Why?
|
| Models, Theoretical | 1 | 2015 | 82 | 0.470 |
Why?
|
| Aging | 8 | 2023 | 1483 | 0.470 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.460 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.460 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.460 |
Why?
|
| DNA Methylation | 5 | 2022 | 157 | 0.450 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 44 | 0.450 |
Why?
|
| Gene Expression | 5 | 2023 | 200 | 0.440 |
Why?
|
| Microglia | 5 | 2023 | 139 | 0.400 |
Why?
|
| Cognition | 6 | 2021 | 1250 | 0.400 |
Why?
|
| Genome, Human | 3 | 2018 | 43 | 0.400 |
Why?
|
| Aged | 19 | 2023 | 8732 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 151 | 0.360 |
Why?
|
| Genotype | 4 | 2019 | 339 | 0.350 |
Why?
|
| Male | 22 | 2022 | 14277 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 25 | 0.350 |
Why?
|
| Female | 21 | 2022 | 14734 | 0.340 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 93 | 0.330 |
Why?
|
| Hormones | 1 | 2010 | 15 | 0.330 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 309 | 0.320 |
Why?
|
| Autopsy | 6 | 2019 | 334 | 0.310 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 79 | 0.290 |
Why?
|
| Cohort Studies | 8 | 2020 | 1806 | 0.280 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 251 | 0.280 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 53 | 0.260 |
Why?
|
| Motor Activity | 2 | 2019 | 317 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 38 | 0.240 |
Why?
|
| Phenotype | 4 | 2023 | 290 | 0.240 |
Why?
|
| Benchmarking | 1 | 2023 | 31 | 0.210 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 235 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 128 | 0.200 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 23 | 0.200 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 17 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 153 | 0.190 |
Why?
|
| Mutation | 2 | 2014 | 341 | 0.190 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 83 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 15 | 0.190 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 33 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.190 |
Why?
|
| Astrocytes | 2 | 2020 | 140 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 109 | 0.180 |
Why?
|
| Neurons | 4 | 2021 | 332 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 17 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2020 | 169 | 0.180 |
Why?
|
| Models, Genetic | 3 | 2020 | 32 | 0.180 |
Why?
|
| Haplotypes | 2 | 2020 | 55 | 0.180 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 186 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 66 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 100 | 0.170 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 6 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 93 | 0.160 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 39 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 179 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 7 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2019 | 14 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 14 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Histones | 1 | 2019 | 31 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| Independent Living | 2 | 2019 | 283 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2019 | 120 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 22 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 78 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 114 | 0.140 |
Why?
|
| Risk Factors | 6 | 2019 | 2237 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1059 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 76 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 16 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 268 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 18 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 127 | 0.130 |
Why?
|
| Postural Balance | 1 | 2018 | 113 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 185 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 267 | 0.130 |
Why?
|
| Exercise | 1 | 2019 | 434 | 0.110 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.110 |
Why?
|
| tau Proteins | 3 | 2021 | 225 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 15 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1150 | 0.110 |
Why?
|
| Mitochondria | 1 | 2014 | 60 | 0.110 |
Why?
|
| Fibromyalgia | 1 | 2014 | 27 | 0.110 |
Why?
|
| Gait | 1 | 2018 | 408 | 0.110 |
Why?
|
| Behavior | 1 | 2013 | 23 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 26 | 0.100 |
Why?
|
| Amygdala | 2 | 2010 | 41 | 0.100 |
Why?
|
| Animals | 5 | 2020 | 3503 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 65 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 29 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 1352 | 0.100 |
Why?
|
| Linear Models | 3 | 2018 | 240 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1333 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 42 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 65 | 0.080 |
Why?
|
| Alleles | 2 | 2021 | 204 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 368 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 263 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 67 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2018 | 50 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 544 | 0.060 |
Why?
|
| Hippocampus | 2 | 2019 | 266 | 0.060 |
Why?
|
| Species Specificity | 2 | 2020 | 37 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 40 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2023 | 10 | 0.050 |
Why?
|
| Meninges | 1 | 2023 | 7 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 105 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 100 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 94 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 577 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 101 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 39 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 20 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 18 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 40 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Lysosomes | 1 | 2020 | 24 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 649 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 106 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 1 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 15 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 214 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 113 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 14 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 571 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 143 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 13 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 14 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 8772 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 77 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 13 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 37 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 98 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 9 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 13 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 119 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 38 | 0.030 |
Why?
|
| Accelerometry | 1 | 2018 | 87 | 0.030 |
Why?
|
| Epigenomics | 1 | 2017 | 18 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 33 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 391 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 92 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 9 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 102 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 205 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 201 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 89 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 337 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 898 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1701 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 7662 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 851 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 14 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 254 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 53 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 54 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 33 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 50 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 143 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 454 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 63 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1757 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 957 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 640 | 0.020 |
Why?
|
| United States | 1 | 2017 | 1989 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 14 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 58 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 96 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 90 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 404 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 227 | 0.020 |
Why?
|